The thymus in myasthenia gravis: Site of "innate autoimmunity"?

Abstract

Myasthenia gravis (MG) is an autoimmune disorder caused, in most cases, by autoantibodies against components of the neuromuscular junction, frequently the acetylcholine receptor (AChR), and less often the muscle-specific kinase receptor. The thymus plays a major role in the pathogenesis of MG with anti-AChR antibodies: it shows marked pathologic alterations (hyperplastic or tumoral) in most AChR-positive patients and contains the elements required to initiate and sustain an autoimmune reaction (AChR autoantigen, AChR-specific T cells, and autoantibody-secreting plasma cells). In this study we review early and more recent findings implicating the thymus as site of AChR autosensitization in MG and briefly discuss the therapeutic role of thymectomy. We also summarize data showing that the MG thymus is in a state of chronic inflammation, and we review emerging evidence of a viral contribution to the onset and maintenance of the thymic autoimmune response.

• Authors: Paola Cavalcante, Rozen Le Panse, Sonia Berrih-Aknin, Lorenzo Maggi, Carlo Antozzi, Fulvio Baggi, Pia Bernasconi, Renato Mantegazza
• Journal: Muscle & nerve (Muscle Nerve) Vol. 44 Issue 4 Pg. 467-84 (Oct 2011) ISSN: 1097-4598 [Electronic] United States
• PMID: 21922466 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2011 Wiley Periodicals, Inc.

Chemical References

• Autoantibodies

Topics

• Autoantibodies (immunology)
• Autoimmune Diseases (immunology, metabolism, pathology)
• Humans
• Immunity, Innate (physiology)
• Myasthenia Gravis (immunology, pathology, therapy)
• Thymus Gland (abnormalities, immunology, metabolism)